BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23736085)

  • 1. Genomics and proteomics: how long do we need to reach clinical results?
    Matafora V; Bachi A; Capasso G
    Blood Purif; 2013; 36(1):7-11. PubMed ID: 23736085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of genomics and proteomics in nephrology.
    Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
    Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
    Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS
    IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteomics and the kidney: an innovative approach to the study of renal disease].
    Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
    G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and proteomic applications in diagnosis of platelet disorders and classification.
    Senzel L; Gnatenko DV; Bahou WF
    Semin Thromb Hemost; 2008 Sep; 34(6):532-8. PubMed ID: 19085652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary gene and protein expression studies and integrative approaches in toxicogenomics.
    Merrick BA; Madenspacher JH
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):189-94. PubMed ID: 15992845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer.
    Nagaraj NS; Singh OV
    Expert Opin Med Diagn; 2009 Mar; 3(2):167-80. PubMed ID: 23485163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a gene-centric human proteome project the best way for proteomics to serve biology?
    Rabilloud T; Hochstrasser D; Simpson RJ
    Proteomics; 2010 Sep; 10(17):3067-72. PubMed ID: 20648483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and proteomic approaches for predicting toxicity and adverse drug reactions.
    Ge F; He QY
    Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):29-37. PubMed ID: 19236227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of Omics research in acupuncture: the relevance and future prospects for understanding the nature of meridians and acupoints.
    Jia J; Yu Y; Deng JH; Robinson N; Bovey M; Cui YH; Liu HR; Ding W; Wu HG; Wang XM
    J Ethnopharmacol; 2012 Apr; 140(3):594-603. PubMed ID: 22322253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and nephrology.
    Bonomini M; Sirolli V; Magni F; Urbani A
    J Nephrol; 2012; 25(6):865-71. PubMed ID: 23042438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
    Thongboonkerd V
    Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From -omics to personalized medicine in nephrology: integration is the key.
    Pesce F; Pathan S; Schena FP
    Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.